Trimethylamine N-oxide (TMAO) in human health
- PMID: 33746664
- PMCID: PMC7975634
- DOI: 10.17179/excli2020-3239
Trimethylamine N-oxide (TMAO) in human health
Abstract
Due to numerous links between trimethylamine-N-oxide (TMAO) and various disorders and diseases, this topic is very popular and is often taken up by researchers. TMAO is a low molecular weight compound that belongs to the class of amine oxides. It is formed by the process of oxidation of trimethylamine (TMA) by the hepatic flavin monooxygenases (FMO1 and FMO3). TMAO is mainly formed from nutritional substrates from the metabolism of phosphatidylcholine/choline, carnitine, betaine, dimethylglycine, and ergothioneine by intestinal microflora in the colon. Its level is determined by many factors, such as age, gender, diet, intestinal microflora composition, kidney function, and also liver flavin monooxygenase activity. Many studies report a positive relationship between the level of TMAO concentration and the development of various diseases, such as cardiovascular diseases and cardiorenal disorders, including atherosclerosis, hypertension, ischemic stroke, atrial fibrillation, heart failure, acute myocardial infarction, and chronic kidney disease, and also diabetes mellitus, metabolic syndrome, cancers (stomach, colon), as well as neurological disorders. In this review, we have summarized the current knowledge on the effects of TMAO on human health, the relationship between TMAO and intestinal microbiota, the role of TMAO in different diseases, and current analytical techniques used in TMAO determination in body fluids.
Keywords: TMA; TMAO; analytical technique; diseases; human health; trimethylamine; trimethylamine N-oxide.
Copyright © 2021 Gatarek et al.
Figures



Similar articles
-
Dietary phenolics and their microbial metabolites are poor inhibitors of trimethylamine oxidation to trimethylamine N-oxide by hepatic flavin monooxygenase 3.J Nutr Biochem. 2023 Oct;120:109428. doi: 10.1016/j.jnutbio.2023.109428. Epub 2023 Aug 5. J Nutr Biochem. 2023. PMID: 37549832
-
Can diet modulate trimethylamine N-oxide (TMAO) production? What do we know so far?Eur J Nutr. 2021 Oct;60(7):3567-3584. doi: 10.1007/s00394-021-02491-6. Epub 2021 Feb 3. Eur J Nutr. 2021. PMID: 33533968 Review.
-
Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk.J Thromb Haemost. 2018 Sep;16(9):1857-1872. doi: 10.1111/jth.14234. Epub 2018 Aug 9. J Thromb Haemost. 2018. PMID: 29981269 Free PMC article.
-
Trimethylamine N-Oxide, the Microbiome, and Heart and Kidney Disease.Annu Rev Nutr. 2017 Aug 21;37:157-181. doi: 10.1146/annurev-nutr-071816-064732. Epub 2017 Jul 17. Annu Rev Nutr. 2017. PMID: 28715991 Review.
-
Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.Life Sci. 2014 Nov 11;117(2):84-92. doi: 10.1016/j.lfs.2014.09.028. Epub 2014 Oct 7. Life Sci. 2014. PMID: 25301199
Cited by
-
1H-NMR metabolomic profile of healthy and osteoarthritic canine synovial fluid before and after UC-II supplementation.Sci Rep. 2022 Nov 16;12(1):19716. doi: 10.1038/s41598-022-23977-1. Sci Rep. 2022. PMID: 36385297 Free PMC article.
-
Alterations in Choline Metabolism in Non-Obese Individuals with Insulin Resistance and Type 2 Diabetes Mellitus.Metabolites. 2024 Aug 18;14(8):457. doi: 10.3390/metabo14080457. Metabolites. 2024. PMID: 39195553 Free PMC article.
-
Gut Microbiota-Derived Trimethylamine Promotes Inflammation with a Potential Impact on Epigenetic and Mitochondrial Homeostasis in Caco-2 Cells.Antioxidants (Basel). 2024 Aug 30;13(9):1061. doi: 10.3390/antiox13091061. Antioxidants (Basel). 2024. PMID: 39334721 Free PMC article.
-
Immune mechanism of gut microbiota and its metabolites in the occurrence and development of cardiovascular diseases.Front Microbiol. 2022 Dec 14;13:1034537. doi: 10.3389/fmicb.2022.1034537. eCollection 2022. Front Microbiol. 2022. PMID: 36590426 Free PMC article. Review.
-
Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease.Lipids Health Dis. 2023 Sep 11;22(1):150. doi: 10.1186/s12944-023-01911-2. Lipids Health Dis. 2023. PMID: 37697333 Free PMC article.
References
-
- Al-Rubaye H, Perfetti G, Kaski JC. The role of microbiota in cardiovascular risk: Focus on trimethylamine oxide. Curr Probl Cardiol. 2019;44:182–196. - PubMed
-
- Awwad HM, Geisel J, Obeid R. Determination of trimethylamine, trimethylamine N-oxide, and taurine in human plasma and urine by UHPLC-MS/MS technique. J Chromatogr B Analyt Technol Biomed Life Sci. 2016;1038:12–18. - PubMed
-
- Bain MA, Faull R, Fornasini G, Milne RW, Evans AM. Affiliations expand accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis. Nephrol Dial Transplant. 2006;21:1300–1304. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical